We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
-0.87%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$46.4B
AUM Growth
+$701M
(+1.5%)
Cap. Flow
+$2.34B
Cap. Flow
% of AUM
5.06%
Top 10 Holdings %
Top 10 Hldgs %
14.53%
Holding
2,237
New
170
Increased
888
Reduced
909
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$197M |
| 2 |
Deckers Outdoor
DECK
|
+$179M |
| 3 |
DexCom
DXCM
|
+$156M |
| 4 |
Teradyne
TER
|
+$154M |
| 5 |
ExxonMobil
XOM
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$163M |
| 2 |
Wingstop
WING
|
+$130M |
| 3 |
ServiceNow
NOW
|
+$108M |
| 4 |
GoDaddy
GDDY
|
+$94.2M |
| 5 |
Vertiv
VRT
|
+$80M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.5% |
| 2 | Healthcare | 16.86% |
| 3 | Financials | 13.55% |
| 4 | Consumer Discretionary | 9.41% |
| 5 | Industrials | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Globus Medical
GMED
$10.1B
| $924K | ﹤0.01% |
12,628
+1,893
| +18% | +$156K |
|
1127
Stride
LRN
$3.41B
| $923K | ﹤0.01% |
7,294
-140
| -2% | -$17.7K |
|
1128
CubeSmart
CUBE
$8.94B
| $915K | ﹤0.01% |
21,415
-846
| -4% | -$35.3K |
|
1129
Range Resources
RRC
$9.08B
| $912K | ﹤0.01% |
22,850
+195
| +0.9% | +$7.5K |
|
1130
ASE Group
ASX
$98.8B
| $912K | ﹤0.01% |
104,136
+3,038
| +3% | +$30.9K |
|
1131
First Bancorp
FBNC
$2.59B
| $903K | ﹤0.01% |
22,488
-3,022
| -12% | -$128K |
|
1132
Paylocity
PCTY
$7.82B
| $902K | ﹤0.01% |
4,815
-140
| -3% | -$28K |
|
1133
Primerica
PRI
$8.98B
| $899K | ﹤0.01% |
3,160
-619
| -16% | -$176K |
|
1134
American Financial Group
AFG
$11.9B
| $898K | ﹤0.01% |
6,839
+14
| +0.2% | +$1.81K |
|
1135
10x Genomics
TXG
$9.47B
| $898K | ﹤0.01% |
+102,863
| New | +$1.3M |
|
|
BERY
1136
DELISTED
Berry Global Group, Inc.
BERY
| $896K | ﹤0.01% |
12,834
-2,716
| -17% | -$189K |
|
1137
Funko
FNKO
$295M
| $895K | ﹤0.01% |
130,527
+1,696
| +1% | +$19.7K |
|
1138
International Paper
IP
$18B
| $895K | ﹤0.01% |
16,783
+15,641
| +1,370% | +$856K |
|
1139
Integra LifeSciences
IART
$1.25B
| $893K | ﹤0.01% |
+40,629
| New | +$955K |
|
1140
Entrada Therapeutics
TRDA
$268M
| $892K | ﹤0.01% |
98,720
-1,094
| -1% | -$13.6K |
|
1141
Omega Healthcare
OHI
$14.2B
| $883K | ﹤0.01% |
23,200
+635
| +3% | +$23.6K |
|
|
DNB
1142
DELISTED
Dun & Bradstreet
DNB
| $883K | ﹤0.01% |
98,795
| – | – |
|
1143
Constellation Energy
CEG
$92B
| $881K | ﹤0.01% |
4,371
-26,434
| -86% | -$7.09M |
|
1144
American Public Education
APEI
$813M
| $879K | ﹤0.01% |
39,364
+78
| +0.2% | +$1.69K |
|
1145
OGE Energy
OGE
$9.5B
| $876K | ﹤0.01% |
19,058
-3,989
| -17% | -$174K |
|
1146
Chemed
CHE
$6.66B
| $875K | ﹤0.01% |
1,422
+14
| +1% | +$7.96K |
|
1147
Carlyle Group
CG
$14.3B
| $871K | ﹤0.01% |
19,983
+2,303
| +13% | +$114K |
|
1148
Alerus Financial
ALRS
$824M
| $868K | ﹤0.01% |
46,997
-582
| -1% | -$11.6K |
|
1149
Signet Jewelers
SIG
$3.94B
| $867K | ﹤0.01% |
14,937
-10,165
| -40% | -$582K |
|
1150
Aramark
ARMK
$15.2B
| $867K | ﹤0.01% |
25,103
-387
| -2% | -$14.3K |
|
Similar funds
Federated Hermes's Q1 2025 Portfolio in Review
As of Q1 2025, Federated Hermes held 2,237 positions worth $46.4B, up 1.5% from $45.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.34B of net new capital in Q1 2025, opening 170 new positions and adding to 888 existing holdings. Its largest new stake was Zscaler: 283,095 shares worth $56.2M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $163M trimmed.
- Federated Hermes's largest Q1 2025 buy was Zscaler: 283,095 shares worth $56.2M.
- Federated Hermes added most to Amgen in Q1 2025, an estimated $197M increase.
- Federated Hermes's biggest Q1 2025 reduction was Gilead Sciences, cutting an estimated $163M.
- Federated Hermes fully exited New Fortress Energy in Q1 2025, selling an estimated $31.4M.
- Federated Hermes's ten largest holdings make up 15% of its $46.4B portfolio in Q1 2025.
- Federated Hermes opened 170 new positions and closed 187 in Q1 2025.
- Federated Hermes's portfolio value rose 1.5% quarter-over-quarter to $46.4B.
Based on Federated Hermes's 13F filing for Q1 2025, filed 8 May 2025.